---
figid: PMC5558882__nihms894159f1
figtitle: Sticking It to Cancer With Molecular Glue For SHP2
organisms:
- Homo sapiens
- Mus musculus
- Diaporthe sclerotioides
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5558882
filename: nihms894159f1.jpg
figlink: /pmc/articles/PMC5558882/figure/F1/
number: F1
caption: Schematics illustrating key features of SHP2 regulation and function.(A)
  SHP2 switches from a closed (inactive) to an “open” active form upon binding to
  specific phosphotyrosyl peptide motifs in RTKs/scaffold proteins.(B) Role of SHP2
  in growth factor/cytokine-dependent RAS/ERK pathway activation (left) and in mediating
  the inhibitory function of PD-1 (and other immune-inhibitory receptors) on TCR signaling
  (right).(C, D) Effects of active site-targeting inhibitor (C) or SHP09 (D) on SHP2.
papertitle: Sticking It to Cancer With Molecular Glue For SHP2.
reftext: Hao Ran, et al. Cancer Cell. ;30(2):194-196.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9726227
figid_alias: PMC5558882__F1
figtype: Figure
redirect_from: /figures/PMC5558882__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5558882__nihms894159f1.html
  '@type': Dataset
  description: Schematics illustrating key features of SHP2 regulation and function.(A)
    SHP2 switches from a closed (inactive) to an “open” active form upon binding to
    specific phosphotyrosyl peptide motifs in RTKs/scaffold proteins.(B) Role of SHP2
    in growth factor/cytokine-dependent RAS/ERK pathway activation (left) and in mediating
    the inhibitory function of PD-1 (and other immune-inhibitory receptors) on TCR
    signaling (right).(C, D) Effects of active site-targeting inhibitor (C) or SHP09
    (D) on SHP2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd274
  - Trav6-3
  - Pdcd1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Grb2
  - CD274
  - HLA-C
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Mhc
  - zip
  - Tcr
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Sos
  - drk
  - MKP-4
  - p38b
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
